RWA.LTD Launches Vietnam Market Expansion: Using Ho Chi Minh City as a Strategic Hub to Explore Southeast Asia Deployment Pathways for Non-Financial RWA

RWA.LTD Launches Vietnam Market Expansion: Using Ho Chi Minh City as a Strategic Hub to Explore Southeast Asia Deployment Pathways for Non-Financial RWA

HONG KONG, Dec. 30, 2025 /PRNewswire/ -- Against the backdrop of real-world asset (RWA) digitization gradually moving from concept to practical application worldwide, Southeast Asia is emerging as a key frontier for the next wave of innovation and...

Dato' Seri Ir. Dr. Zaini Ujang's conferred the 'Professor Emeritus' title in conjunction with MK69 UTM

Dato' Seri Ir. Dr. Zaini Ujang's conferred the 'Professor Emeritus' title in conjunction with MK69 UTM

Distinguished UTM alumnus and national leader honoured for his leadership, scholarship, and impact on global standing. JOHOR BAHRU, Malaysia, Dec. 22, 2025 /PRNewswire/ -- After an illustrious 37-year career in academia and public service, Dato'...

High Response in Bladder Cancer: Immvira Announced Its MVR-T3011 Latest Clinical Results in BCG-Unresponsive Bladder Cancer Patients at 2025 Annual Meeting of the Society of Urologic Oncology

High Response in Bladder Cancer: Immvira Announced Its MVR-T3011 Latest Clinical Results in BCG-Unresponsive Bladder Cancer Patients at 2025 Annual Meeting of the Society of Urologic Oncology

SUZHOU, China, Dec. 4, 2025 /PRNewswire/ -- On December 3, 2025 (local time in Arizona, USA), ImmVira Group ("ImmVira" or the "Company") announced a poster presentation at the 26th Annual Meeting of the Society of Urologic Oncology (SUO 2025). The...

The Annals of Oncology Publishes Results of Phase II Study of Sacituzumab Tirumotecan Monotherapy for Urothelial Carcinoma

The Annals of Oncology Publishes Results of Phase II Study of Sacituzumab Tirumotecan Monotherapy for Urothelial Carcinoma

CHENGDU, China, Nov. 28, 2025 /PRNewswire/ -- Recently, Clinical study results from Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", HKEX: 6990)'s TROP2 ADC sacituzumab tirumotecan (sac-TMT) monotherapy for advanced or metastatic...

JSAUX Kicks Off Black Friday Event with Major Savings on Gaming Accessories

JSAUX Kicks Off Black Friday Event with Major Savings on Gaming Accessories

HONG KONG, Nov. 20, 2025 /PRNewswire/ -- Tech manufacturer JSAUX has initiated its annual Black Friday promotion , offering discounts on various gaming peripherals and accessories. The sale is available through both the company's official website...

First Flock of 19 Whooper Swans Arrives in Rongcheng for Winter

First Flock of 19 Whooper Swans Arrives in Rongcheng for Winter

WEIHAI, China, Nov. 3, 2025 /PRNewswire/ -- A news report from CRI Online: The first flock of 19 whooper swans has been spotted at Rongcheng Swan Lake, marking the official start of the swan season in the coastal city. Staff at the Rongcheng...

Zhimeng Biopharma's investigational drug CB03-154 for amyotrophic lateral sclerosis has achieved the first patient first dose milestone in the phase 2/3 pivotal clinical trial.

Zhimeng Biopharma's investigational drug CB03-154 for amyotrophic lateral sclerosis has achieved the first patient first dose milestone in the phase 2/3 pivotal clinical trial.

SHANGHAI, Oct. 31, 2025 /PRNewswire/ -- Shanghai Zhimeng Biopharma Inc. ( "Zhimeng") announced that its self-developed new-generation potassium channel opener CB03-154 for the treatment of amyotrophic lateral sclerosis (ALS) has officially initiated...

MetaOptics Announces Strategic Expansion into the USA with Nevada Incorporation and Advanced 127μm Co-Packaged Optics Breakthrough

MetaOptics Announces Strategic Expansion into the USA with Nevada Incorporation and Advanced 127μm Co-Packaged Optics Breakthrough

SINGAPORE, Oct. 29, 2025 /PRNewswire/ -- MetaOptics Ltd (Catalist: 9MT) ("MetaOptics"), a leading-edge semiconductor optics company pioneering metalens technology, is pleased to announce the establishment of its United States entity, MetaOptics Inc....

BioDlink Completes First International Shipment of Bevacizumab to Colombia

BioDlink Completes First International Shipment of Bevacizumab to Colombia

Bevacizumab is a targeted therapy used to treat lung and colorectal cancers, both among the top three cancers ranked by death in Colombia[1]. This inaugural shipment—dispatched around two months after Colombia's marketing approval—demonstrates the...

Kelun-Biotech Presents Positive Phase 3 Data for Trastuzumab Botidotin Compared to T-DM1 at 2025 ESMO

Kelun-Biotech Presents Positive Phase 3 Data for Trastuzumab Botidotin Compared to T-DM1 at 2025 ESMO

CHENGDU, China, Oct. 20, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that at the 2025 European Society for Medical Oncology (ESMO) Congress held in Berlin, Germany, Results from a Phase 3 study of...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • menu
    menu